Abstract

Introduction and Aim: The metabolic and oxidative stress induces highly reactive free radicals that are known to harm normal physiology and play a role in the development of cancer. Elevated levels of these free radicals contribute to excessive neovascularization leading to angiogenesis mediated cancer progression. Targeting these free radicals through dietary source is important strategy in regulation of cancer. Allium sativum L. (AsL) garlic has important multi pharmacological properties. On the other hand, dietary lectins are proven to be the best anti-cancer molecules. The study presents investigation that focus to assess the antioxidant, immunomodulatory and anticancer activities of partially purified garlic lectin (PPAsL). Materials and Methods: Fresh garlic bulbs were processed and evaluated for lectin induced HA activity. Further the garlic lectins (AsL) were partially purified by ammonium sulphate precipitation and dialysis and analyzed through SDS-PAGE. Further lectins were characterized by producing Anti-AsL polyclonal antibodies and purification by affinity chromatography. Pharmacological evaluations of the lectins were assessed through antioxidant, anti-proliferative and antiangiogenic mediated anti-cancer activity. Results: Lectin positive activity was confirmed by HA activity and partial purification lectin identified ?12kDa protein having Glc/Man glycan specificity. The polyclonal antibodies raised against PPAsL, confirmed that it has potent immunogen. Pharmacological evaluation confirmed that PPAsL has potent antioxidant, antiangiogenic and antiproliferative effect both in-vitro and in-vivo. Conclusion: PPAsL is potent antioxidant, anti-proliferative and anti-cancer molecule. The dietary recommendation of the garlic lectin is an important therapeutic strategy against the cancer.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call